Tech Company Financing Transactions
Nephronomics Funding Round
Nephronomics, operating out of Dover, secured investment capital from CerraCap Ventures.
Transaction Overview
Company Name
Announced On
4/22/2026
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8 The Green 15195
Dover, DE 19901
USA
Dover, DE 19901
USA
Phone
Website
Email Address
Overview
Nephronomics is a precision medicine company vertically integrating the world's most robust cardio-kidney-metabolic disease database of clinical and genomic data and ML models to develop targeted therapies against the underlying molecular mechanisms. Nephronomics aims to redefine and refine renal disease categories by reconceptualizing traditional diagnostic terms and identifying clinically relevant subtypes within the CKM spectrum.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
Deniz Kural
Founder
Benjamin Hippen
Founder
James Sietstra
Founder
Jan Walter
Browse more venture capital transactions:
Prev: 4/22/2026: Omeza venture capital transaction
Next: 4/22/2026: A&K Robotics venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs